Halliburton Q1 2026 Earnings: Cost Saves Offset NA Softness, International Stable

What happened

Halliburton's Q1 2026 earnings, reported on April 27, showed revenue and EPS against expectations, with cost actions of ~$100M per quarter cushioning a high-single-digit decline in North America revenue, consistent with prior guidance. The quarter confirmed ongoing pricing pressure in U.S. Land stimulation, as frac spreads remain down 19% year-over-year, but fleet stacking and the Zeus electric transition are preventing a more severe margin collapse. International revenue stayed 'stable' as guided, with no acceleration yet from the completion tools order book, although the Nigeria integrated contract provides long-term pipeline support. Free cash flow of $828M in Q1 supports the >50% return framework, but insider selling by the CEO and other executives ahead of the report raises caution on management's confidence in a sustained recovery. Overall, the quarter validates the base case of margin defense but offers no catalyst for re-rating, keeping the stock in a wait-and-see posture until U.S. frac spreads stabilize or international awards convert to revenue.

Implication

Near-term, the earnings reinforce that Halliburton can defend 2025 margins via cost savings, but the lack of pricing improvement in U.S. Land caps upside above $45. The $100M quarterly cost saves are flowing through but are one-time and will be lapped by Q3, so sustainable margin expansion requires utilization recovery. International remains a waiting game: the all-time high completion tools order book is not yet translating into revenue, and the key catalyst is new integrated offshore awards like Nigeria. Insider selling by the CEO and EVPs at ~$32-$40 is a concerning signal, suggesting limited upside from current levels. With the stock at ~$38 after the print, we see limited upside to the $38 base case and downside risk to $28 if U.S. pricing further deteriorates; we recommend waiting for a better entry near $32 or a clear catalyst.

Thesis delta

The Q1 2026 earnings do not alter the core thesis that Halliburton is executing on margin defense but lacks organic growth catalysts. The quarter confirms that North America pricing remains under pressure and international growth has not yet materialized, keeping the stock in the WAIT zone. No shift is warranted; the expected path to upside—U.S. frac spread stabilization and international order book conversion—remains unconfirmed.